title: Question 3. Should stimulants be administered to manage difficulties with attention, hyperactivity and impulsivity following paediatric acquired brain injury?
authors.affiliation: Clinical Psychology, University of Leeds, Leeds, UK.
authors.forename: David W
authors.initials: DW
authors.lastname: Harvey
authors.forename: Matthew
authors.initials: M
authors.lastname: Morrall
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Neilly
authors.forename: Deborah
authors.initials: D
authors.lastname: Murdoch-Eaton
mesh_terms: D000063:Accidents, Traffic; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000209:etiology; D001930:Brain Injuries / Q000150:complications*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D019317:Evidence-Based Medicine; D006801:Humans; D007175:Impulsive Behavior / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate